Featured Content

New Algorithm Improves Outcome Prediction for Diffuse Large B-Cell Lymphoma

The model was developed using machine learning techniques and programmed with data from a Danish cancer registry.

Moving Targets: Off-Label Prescribing of Targeted Therapies

By way of the TAPUR study, researchers are attempting to evaluate the activity of targeted therapies when they are used in an off-label setting.

The Patient Behind the EHR: Oncologists Only See Half the Picture

Dr Vorobiof discusses the importance patient factors that can be missed via standard data collection methods for patients with cancer.

Tackling EBV-Associated Lymphoma: Early Research Finds Overall Survival Benefit After Donor Transplants

Use of experimental T cells that target Epstein-Barr virus proteins in relapsed or refractory lymphoma may improve overall survival.

Younger Women May Have Better Chance at Ovarian Function Recovery After Treatment for Hodgkin Lymphoma

Women aged 35 years or older diagnosed with Hodgkin lymphoma should discuss fertility preservation prior to treatment.

More Features>>>

Video Series

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs